Cystic fibrosis mutation screening using the NGEN CFTR ASRs for genotyping the ACOG/ACMG 23 recommended mutations

被引：0
|
作者：
Conklin, J. A.
Bentley, H. A.
Yeo, K.
Tsongalis, G. J.
机构：
[1] Dartmouth Coll Sch Med, Lebanon, NH USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2006年 / 8卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：626 / 626
页数：1
相关论文
共 50 条
  • [31] Spectrum of CFTR gene mutations in Ecuadorian cystic fibrosis patients: the second report of the p.H609R mutation
    Ortiz, Sofia C.
    Aguirre, Santiago J.
    Flores, Sofia
    Maldonado, Claudio
    Mejia, Juan
    Salinas, Lilian
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2017, 5 (06): : 751 - 757
  • [32] Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation
    Pissarra, Luisa S.
    Farinha, Carlos M.
    Xu, Zhe
    Schmidt, Andre
    Thibodeau, Patrick H.
    Cai, Zhiwei
    Thomas, Philip J.
    Sheppard, David N.
    Amaral, Margaricla D.
    CHEMISTRY & BIOLOGY, 2008, 15 (01): : 62 - 69
  • [33] Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding site
    Molinski, Steven V.
    Shahani, Vijay M.
    Subramanian, Adithya S.
    MacKinnon, Stephen S.
    Woollard, Geoffrey
    Laforet, Marcon
    Laselva, Onofrio
    Morayniss, Leonard D.
    Bear, Christine E.
    Windemuth, Andreas
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2018, 86 (08) : 833 - 843
  • [34] RETROSPECTIVE STUDY OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE-MUTATIONS IN GUTHRIE CARDS FROM A LARGE COHORT OF NEONATAL SCREENING FOR CYSTIC-FIBROSIS
    VERLINGUE, C
    MERCIER, B
    LECOQ, I
    AUDREZET, MP
    LAROCHE, D
    TRAVERT, G
    FEREC, C
    HUMAN GENETICS, 1994, 93 (04) : 429 - 434
  • [35] Analysis of 31 CFTR mutations by polymerase chain reaction oligonucleotide ligation assay in a pilot screening of 4476 newborns for cystic fibrosis
    Gasparini, P
    Arbustini, E
    Restagno, G
    Zelante, L
    Stanziale, P
    Gatta, L
    Sbaiz, L
    Sedita, AM
    Banchieri, N
    Sapone, L
    Fiorucci, GC
    Brinson, E
    Shulse, E
    Rappaport, E
    Fortina, P
    JOURNAL OF MEDICAL SCREENING, 1999, 6 (02) : 67 - 69
  • [36] CFTR mutation distribution among US Hispanic and African American individuals:: Evaluation in cystic fibrosis patient and carrier screening populations
    Sugarman, EA
    Rohlfs, EM
    Silverman, LM
    Allitto, BA
    GENETICS IN MEDICINE, 2004, 6 (05) : 392 - 399
  • [37] Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and the CFTR mutation tests (vol 7, pg 317, 2005)
    Ogino, S
    Flodman, P
    Wilson, RB
    Gold, B
    Grody, W
    GENETICS IN MEDICINE, 2005, 7 (06) : 460 - 460
  • [38] DISCRIMINATION BETWEEN RECURRENT MUTATION AND IDENTITY BY DESCENT - APPLICATION TO POINT MUTATIONS IN EXON-11 OF THE CYSTIC-FIBROSIS (CFTR) GENE
    REISS, J
    COOPER, DN
    BAL, J
    SLOMSKI, R
    CUTTING, GR
    KRAWCZAK, M
    HUMAN GENETICS, 1991, 87 (04) : 457 - 461
  • [39] SCREENING FOR NON-DELTAF508 MUTATIONS IN 5 EXONS OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE IN ITALY
    DEVOTO, M
    RONCHETTO, P
    FANEN, P
    ORRIOLS, JJT
    ROMEO, G
    GOOSSENS, M
    FERRARI, M
    MAGNANI, C
    SEIA, M
    CREMONESI, L
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 48 (06) : 1127 - 1132
  • [40] Immunoreactive trypsin/DNA newborn screening for cystic fibrosis:: Should the R117H variant be included in CFTR mutation panels?
    Scotet, Virginie
    Audrezet, Marie-Pierre
    Roussey, Michel
    Rault, Gilles
    Dirou-Prigent, Anne
    Journel, Hubert
    Moisan-Petit, Valerie
    Storni, Veronique
    Ferec, Claude
    PEDIATRICS, 2006, 118 (05) : E1523 - E1529
12345